By InvitationNot Applicable

Long Term Follow up of the LTOG Cohort

United States4,000 participantsStarted 2021-06-15

Plain-language summary

The purpose of the study is to follow participants who enrolled in the Lung Transplant Outcomes Group. Clinical data, functional assessments, and surveys will be collected to determine long term graft function and functional status of lung transplant recipients.

Who can participate

Age range13 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria Long-term phenotyping of CLAD * Lung transplant recipients who have previously enrolled in the LTOG cohort studies at one of the participating centers Long-term functional status and well-being * Lung transplant recipients who have previously enrolled in the LTOG cohort studies at one of the participating centers * Alive Exclusion Criteria Long-term phenotyping of CLAD * Lung transplant recipient not enrolled in LTOG cohort research studies Long-term functional status and well-being * Lung transplant recipient not enrolled in the LTOG cohort research studies * Lung transplant recipient not receiving post-transplant follow-up care at a participating LTOG center

What they're measuring

Chronic Lung Allograft Dysfunction (CLAD) phenotyping

Timeframe: From date of transplant to the development of CLAD, up to 25 years

Functional status phenotyping

Timeframe: From date of transplant to until study termination, withdrawal, or no longer being seen for follow-up at the participating center, up to 25 years

Well being phenotyping-LT-VLA

Timeframe: From date of transplant to until study termination, withdrawal, or no longer being seen for follow-up at the participating center, up to 25 years

Well being phenotyping-LT-QOL

Timeframe: From date of transplant to until study termination, withdrawal, or no longer being seen for follow-up at the participating center, up to 25 years

Trial details

NCT IDNCT04787822

SponsorUniversity of Pennsylvania

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-05-31

View on ClinicalTrials.gov More Lung Transplant Failure and Rejection trials

Who can participate

Age range13 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Chronic Lung Allograft Dysfunction (CLAD) phenotyping

Timeframe: From date of transplant to the development of CLAD, up to 25 years

Functional status phenotyping

Timeframe: From date of transplant to until study termination, withdrawal, or no longer being seen for follow-up at the participating center, up to 25 years

Well being phenotyping-LT-VLA

Timeframe: From date of transplant to until study termination, withdrawal, or no longer being seen for follow-up at the participating center, up to 25 years

Well being phenotyping-LT-QOL

Timeframe: From date of transplant to until study termination, withdrawal, or no longer being seen for follow-up at the participating center, up to 25 years